ArticleFrontiers in medicine2026
Clinical efficacy analysis of acupuncture combined with anti-tumor necrosis factor treatment for spleen and kidney yang deficiency type ulcerative colitis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This study aims to investigate the clinical effects of acupuncture combined with tumor necrosis factor inhibitors in treating spleen-kidney yang deficiency type ulcerative colitis, with hopes of providing new ideas and methods for UC treatment. Methods: We conducted a retrospective cohort study, collecting clinical data from 90 patients diagnosed with spleen and kidney yang deficiency type UC at our hospital between September 2020 and September 2024. All patients were assessed through TCM syndrome differentiation and confirmed by Western medical diagnosis. Patients were divided into a control group ( Results: The results showed that after 12 weeks of treatment, the Mayo scores and TCM syndrome scores at the 6th and 12th weeks in the study group were significantly lower than before treatment ( Conclusion: This study demonstrates that in treating UC with spleen-kidney yang deficiency, acupuncture combined with TNF-α inhibitors can effectively improve patients' clinical symptoms and mucosal healing rates, while also reducing short-and medium-term colectomy rates without increasing the incidence of adverse events. These findings suggest a potential synergistic benefit, warranting confirmation in large-scale, prospective trials.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.